Cost, outcomes, treatment pathways and challenges for diabetes care in Italy

Globalization and Health

Panos Kanavos²  Federico Grimaccia¹ 

[1] Dipartimento Scienze Biomediche e Sanità Pubblica, Università Politecnica delle Marche (UNIVPM), via Tronto, 10/A, Torrette di Ancona, AN 60126, Italy;LSE Health, The London School of Economics and Political Science, Houghton Street, London WC2A 2AE, UK

关键词: Outcomes;    Costs;    Complications;    Italy;    Diabetes;   

Others  :  1175249
DOI  :  10.1186/1744-8603-10-58

 received in 2013-06-25, accepted in 2014-06-11,  发布年份 2014

【 摘 要 】

Background

In Italy both incidence and prevalence of diabetes are increasing and age at diagnosis is decreasing in type 2 diabetes. Diabetes is one of the major causes of morbidity in Italy, causing several disabilities and affecting the economically active population. The objective of this paper is to identify and discuss costs, outcomes and some of the challenges of diabetes care in Italy in the context of recent policy changes.

Methods

The study collected data and evidence from both primary and secondary sources. A total of 10 experts, including clinicians (diabetologists/endocrinologists) and decision makers, both at national and regional levels, were interviewed through face-to-face semi-structured interviews. The secondary sources include peer review literature from Medline, grey literature, reports from national and international sources, including professional bodies and organizations.

Results

The total direct cost of diabetes for the Italian NHS in 2012 is estimated to be above €9 billion, of which more than half for hospital admissions (57%), and the remaining half for drugs (30%) and outpatient care (13%). However, there is scant evidence on indirect and intangible costs of diabetes in Italy. The quality of care addressed via the AMD Annals found overall good performance with both process and intermediate outcome indicators showing positive and improving results from 2004 to 2011, except for few parameters, including renal function and foot monitoring, which are still inadequate. Major challenges are the rising diabetes prevalence, the difficulty in meeting the rising demand for care and the scant development of multidisciplinary delivery of care, especially in the predominantly ambulatory setting of the Southern diabetes centres.

Conclusions

Prevention of diabetes, especially adopting a multi-sectorial approach, should be further empowered by policy makers through promoting healthy lifestyles and specifically targeting child obesity. Other key strategies include more information and education, better diabetes management through the adoption of a chronic model of care, more focus on appropriateness and efficiency of care and better communication between diabetes centres within every Region.

【 授权许可】

   
2014 Grimaccia and Kanavos; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]ISTAT: Annuario Statistico ISTAT. 2013. Available from the ISTAT website [http://www.istat.it/en/files/2013/12/ASI_2013.pdf webcite]
• [2]ISS. Istituto Superiore della Sanità: Centro Nazionale Di Epidemiologia, Sorveglianza E Promozione Della Salute (Cnesps). In PASSI System. Progressi delle Aziende Sanitarie per la Salute in Italia: La sorveglianza Passi; 2011. [http://www.epicentro.iss.it/passi/dati/diabete.asp webcite]
• [3]Gazzetta Ufficiale n.71, 26 March 1987. Law n.115 of 16 March 1987. Disposizioni per la prevenzione e la cura del diabete mellito
• [4]Arcangeli A, Cimino A, Di Bartolo P, Fava D, Lovagnini Scher A, Giorda CB, Marangoni A, Meloncelli I, Mulas MF, Nicolucci A, Nogara A, Pellegrini F, Rossi MC, Turco S, Vespasiani G: Annali AMD, Edizione. Analisi Prospettica Degli Indicatori Dell’assistenza Del Diabete In Italia (2004–2011) 2012.
• [5]Ministry of Health Website[http://www.salute.gov.it/portale/ministro/p4_5_9_2.jsp?lingua=italiano&label=commissioni&menu=organizzazione&id=1031 webcite]
• [6]Piano per la malattia diabetica. Gazzetta Ufficiale n. 32, 07 February13, Supplemento ordinario n. 9 [http://www.salute.gov.it/imgs/C_17_pubblicazioni_1885_allegato.pdf]
• [7]Gazzetta Ufficiale n.33, 8 February 2002.LEA, Livelli Essenziali di Assistenza. Decreto Presidente del Consiglio dei Ministri, 29 Novembre 2001
• [8]Lucioni C, Garancini MP, Massi-Benedetti M, Mazzi S, Serra G: CODE-2 Italian advisory board. The costs of type 2 diabetes mellitus in Italy: a CODE-2 sub-study. Treat Endocrinol 2003, 2:121-133.
• [9]Osservatorio Arno diabete: Analisi Di Dieci Anni Di Prescrizioni. In Rapporto 2007 - Volume XI - Collana “Rapporti ARNO”. CINECA - SISS - Sistemi Informativi e Servizi per la Sanità; [http://osservatorioarno.cineca.org webcite]
• [10]Osservatorio Arno diabete: Il profilo assistenziale della popolazione con diabete. In Rapporto 2011, Volume XVII - Collana “Rapporti ARNO”. CINECA - SISS - Sistemi Informativi e Servizi per la Sanità; [http://osservatorioarno.cineca.org webcite]
• [11]Profili di assistenza e costi del diabete in Emilia-Romagna: Analisi Empirica Attraverso Dati Amministrativi (2005–2007). Dossier 179–2009
• [12]Scarcella C, Indelicato A, Levaggi R, Lonati F, Magoni M, Cascio S: Il costo del diabete: l’esperienza dell’ASL di Brescia. Pharmacoecon Ital Res Articles 2006, 8(2):95-10.
• [13]Bruno G, Karaghiosoff L, Merletti F, Costa G, DeMaria M, Panero F, Segre O, Cavallo-Perin P, Gnavi R: The impact of diabetes on prescription drug costs: the population-based Turin study. Diabetologia 2008, 51:795-801.
• [14]Changing Diabetes Barometer Italia: Second Barometer Report. 2010.
• [15]ISS. Istituto Superiore della Sanità: Guadagnare Salute Project. 2007. [http://www.salute.gov.it/imgs/C_17_pubblicazioni_605_allegato.pdf webcite]
• [16]IGEA Project. [http://www.epicentro.iss.it/igea/default.asp webcite]